title: Research advancement in local ablation therapy for liver cancer.
abstract: After developing for more than 20 years, image-guided local ablation therapy has become one of the major treatments of hepatocellular carcinoma (HCC). In particular, percutaneous radio-frequency ablation has been widely accepted as the first-line treatment of early-stage HCC. A number of randomized controlled trials have shown some differences between these local ablation techniques. This article reviewed the development of local ablation therapy in the past few years.
authors.affiliation: State Laboratory of Oncology in South China, Guangdong, P. R. China.
authors.forename: Ying-Bin
authors.initials: YB
authors.lastname: Zheng
authors.forename: Yun
authors.initials: Y
authors.lastname: Zheng
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000601:surgery*; D017115:Catheter Ablation / Q000379:methods*; D000431:Ethanol / Q000008:administration & dosage; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000601:surgery*; D008872:Microwaves / Q000627:therapeutic use; D011183:Postoperative Complications; D015641:Radiography, Interventional; D016032:Randomized Controlled Trials as Topic; D018084:Ultrasonography, Interventional
chemical_list: D000431:Ethanol